|
NEK2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.201800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.915400E-01 |
| Normal-vs-Stage2 |
2.009200E-01 |
| Normal-vs-Stage3 |
9.078200E-01 |
| Normal-vs-Stage4 |
5.277600E-01 |
| Stage1-vs-Stage2 |
1.699010E-03 |
| Stage1-vs-Stage3 |
8.139400E-01 |
| Stage1-vs-Stage4 |
2.385600E-01 |
| Stage2-vs-Stage3 |
3.010200E-02 |
| Stage2-vs-Stage4 |
2.937900E-03 |
| Stage3-vs-Stage4 |
2.631800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.099200E-01 |
| Normal-vs-AfricanAmerican |
8.183800E-01 |
| Normal-vs-Asian |
8.362400E-01 |
| Caucasian-vs-AfricanAmerican |
6.646400E-01 |
| Caucasian-vs-Asian |
5.019800E-01 |
| AfricanAmerican-vs-Asian |
9.454000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.635400E-01 |
| Normal-vs-Female |
7.981400E-01 |
| Male-vs-Female |
2.285000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.215800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.612200E-01 |
| Normal-vs-Age(61-80Yrs) |
9.646600E-01 |
| Normal-vs-Age(81-100Yrs) |
8.824100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.680100E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.314800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.185600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.849600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.299030E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.033200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.966200E-01 |
| Classical-VS-Follicular |
1.552850E-04 |
| Classical-VS-Other |
1.327150E-01 |
| Classical-VS-Normal |
8.027600E-01 |
| Tall-VS-Follicular |
3.186100E-02 |
| Tall-VS-Other |
1.691800E-01 |
| Tall-VS-Normal |
6.575800E-01 |
| Follicular-VS-Other |
6.892600E-01 |
| Follicular-VS-Normal |
2.073400E-01 |
| Other-VS-Normal |
4.651600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.557000E-01 |
| Normal-vs-N1 |
8.856600E-01 |
| N0-vs-N1 |
3.455000E-01 |
|
|
